In Vitro and In Vivo Cytotoxicities and Antileishmanial Activities of Thymol and Hemisynthetic Derivatives

Simple item page
dc.contributor.authorSara M. Robledo
dc.contributor.authorEdison Osorio
dc.contributor.authorDiana L. Muñoz
dc.contributor.authorLuz Jaramillo
dc.contributor.authorAdriana Restrepo
dc.contributor.authorGabriel Jaime Murillo Arango
dc.contributor.authorIván Darío Vélez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:02:19Z
dc.date.available2026-03-22T14:02:19Z
dc.date.issued2005
dc.descriptionCitaciones: 100
dc.description.abstractThe in vitro and in vivo antileishmanial and cytotoxic activities of thymol and structural derivatives in comparison to those of Glucantime were studied. The results showed here suggest that thymol and hemisynthetic derivatives have promising antileishmanial potential and could be considered as new lead structures in the search for novel antileishmanial drugs.
dc.identifier.doi10.1128/aac.49.4.1652-1655.2005
dc.identifier.urihttps://doi.org/10.1128/aac.49.4.1652-1655.2005
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44177
dc.language.isoen
dc.publisherAmerican Society for Microbiology
dc.relation.ispartofAntimicrobial Agents and Chemotherapy
dc.sourceCentro Nacional de Enfermedades Tropicales
dc.subjectIn vivo
dc.subjectThymol
dc.subjectIn vitro
dc.subjectChemistry
dc.subjectPharmacology
dc.subjectBiology
dc.titleIn Vitro and In Vivo Cytotoxicities and Antileishmanial Activities of Thymol and Hemisynthetic Derivatives
dc.typearticle

Files

Collections

Artículo Científico Publicado